Target
Interleukin-1 receptor-associated kinase 4
Ligand
BDBM310025
Substrate
n/a
Meas. Tech.
IRAK4 Inhibition Assay
IC50
1.50±n/a nM
Citation
 Bhide, RSDuncia, JVHynes, JNair, SKPitts, WJKumar, SRGardner, DSMurugesan, NPaidi, VRSantella, JBSistla, RKWu, H Heteroaryl substituted pyridyl compounds useful as kinase modulators US Patent  US10544133 Publication Date 1/28/2020 
Target
Name:
Interleukin-1 receptor-associated kinase 4
Synonyms:
IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64
Type:
Protein
Mol. Mass.:
51519.08
Organism:
Homo sapiens (Human)
Description:
Q9NWZ3
Residue:
460
Sequence:
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
  
Inhibitor
Name:
BDBM310025
Synonyms:
US10544133, Example 28 | US9657009, 28
Type:
Small organic molecule
Emp. Form.:
C21H26ClN7O2
Mol. Mass.:
443.93
SMILES:
CC(C)Nc1cc(Nc2ncc(cc2Cl)C#N)ncc1C(=O)NCC[C@@H](C)NC(C)=O |r|
Structure:
Search PDB for entries with ligand similarity: